Shirley Ryan Abilitylab

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.1M in lobbying spend across 32 quarterly filings, Shirley Ryan Abilitylab is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2025.

$1.1M
Total Spend
8
Years Active
1
Firms Hired
4
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$120K
2019$120K
2020$120K
2021$140K
2022$150K
2023$160K
2024$160K
2025$160K

Issues Lobbied

Medicare/MedicaidBudget/Appropriations

Lobbying Firms

Faegre Drinker Biddle & Reath LLP

Lobbyists

Jim TwaddellIlisa Halpern PaulJulie HyamsEdwin Getz

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations

  • •Impatient rehabilitation issues; HR 4582/S 2204 Preserving Rehabilitation Innovation Centers Act.
  • •Inpatient Rehabilitation issues; S. 594, H.R. 1901 Preserving Rehabilitation Innovation Centers Act.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
National Association of Children's Hospitals (N.a.c.h.)
$38.0M total spend
Kaiser Foundation Health Plan INC
$31.5M total spend
American Clinical Laboratory Assn
$23.9M total spend
HCA Healthcare, INC.
$22.7M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.